001     284092
005     20260126112042.0
024 7 _ |a 10.1016/j.coviro.2016.04.002
|2 doi
024 7 _ |a 1879-6257
|2 ISSN
024 7 _ |a 1879-6265
|2 ISSN
037 _ _ |a DZNE-2026-00100
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Secchim Ribeiro, Lucas
|0 P:(DE-2719)9001782
|b 0
|u dzne
245 _ _ |a Zika crisis in Brazil: challenges in research and development
260 _ _ |a Amsterdam [u.a.]
|c 2016
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1769422797_1864
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Infection with the Zika virus (ZIKV) usually causes a mild acute illness, but two major severe syndromes have been described during the epidemic in Brazil: microcephaly and the Guillain-Barré Syndrome. There is now much evidence to show that ZIKV can infect and damage neuronal cells in vitro. In experimental animals, ZIKV has significant neurotropism and can cause brain damage. At present, diagnosis is still a challenge in the field and there is no treatment available. Another major challenge is that one must devise therapies for pregnant women, at all stages of pregnancy. Devising adequate treatment for ZIKV infections represents a challenge that will only be met by the joint effort of the research community.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: pub.dzne.de
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Brazil
|2 MeSH
650 _ 2 |a Disease Models, Animal
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Guillain-Barre Syndrome: virology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Infant, Newborn
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Microcephaly: virology
|2 MeSH
650 _ 2 |a Pregnancy
|2 MeSH
650 _ 2 |a Primates
|2 MeSH
650 _ 2 |a Zika Virus: isolation & purification
|2 MeSH
650 _ 2 |a Zika Virus: pathogenicity
|2 MeSH
650 _ 2 |a Zika Virus Infection: drug therapy
|2 MeSH
650 _ 2 |a Zika Virus Infection: immunology
|2 MeSH
650 _ 2 |a Zika Virus Infection: therapy
|2 MeSH
650 _ 2 |a Zika Virus Infection: virology
|2 MeSH
700 1 _ |a Marques, Rafael Elias
|b 1
700 1 _ |a Jesus, Amélia Maria Ribeiro de
|b 2
700 1 _ |a Almeida, Roque Pacheco de
|b 3
700 1 _ |a Teixeira, Mauro Martins
|b 4
773 _ _ |a 10.1016/j.coviro.2016.04.002
|g Vol. 18, p. 76 - 81
|0 PERI:(DE-600)2611378-8
|p 76 - 81
|t Current opinion in virology
|v 18
|y 2016
|x 1879-6257
856 4 _ |u https://pub.dzne.de/record/284092/files/DZNE-2026-00100_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/284092/files/DZNE-2026-00100_Restricted.pdf?subformat=pdfa
|x pdfa
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 0
|6 P:(DE-2719)9001782
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CURR OPIN VIROL : 2022
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1120
|2 StatID
|b BIOSIS Reviews Reports And Meetings
|d 2025-01-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-02
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CURR OPIN VIROL : 2022
|d 2025-01-02
920 _ _ |l yes
980 _ _ |a journal
980 _ _ |a I:(DE-2719)1040260
980 1 _ |a EXTERN4VITA


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21